Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

629
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
629

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Design principles of the cytotoxic CD8<sup>+</sup> T cell response.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells.

Cell·2026
Same author

Learning the Principles of T Cell Antigen Discernment.

Annual review of biophysics·2026
Same author

A capture assay to analyse immunoglobulin secretion at the single-cell level.

bioRxiv : the preprint server for biology·2026
Same author

Design principles of the cytotoxic CD8<sup>+</sup> T-cell response.

ArXiv·2025
Same author

Design principles of the cytotoxic CD8<sup>+</sup> T-cell response.

bioRxiv : the preprint server for biology·2025

相关实验视频

Updated: Aug 17, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.3K

工程时间控制免疫疗法

Emanuel Salazar-Cavazos1, Grégoire Altan-Bonnet1

  • 1Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Science (New York, N.Y.)
|December 15, 2022
PubMed
概括

设计性淋巴细胞提供了治疗疾病的新途径, 这些工程免疫细胞对未来的治疗应用具有重大前景.

科学领域:

  • 免疫学
  • 生物技术
  • 细胞疗法

背景情况:

  • 目前各种疾病的治疗方法都有局限性.
  • 人们越来越需要创新的治疗策略.
  • 工程细胞提供了针对性治疗的潜力.

研究的目的:

  • 探索设计性淋巴细胞在疾病治疗中的潜力.
  • 展示这些细胞提供的扩大治疗可能性.
  • 为了突出细胞工程的进步,

主要方法:

  • 转基因淋巴细胞的发展.
  • 在体外和体内测试设计性淋巴细胞的疗效.
  • 免疫反应和治疗结果的分析.

主要成果:

  • 设计性淋巴细胞表现出与天然同类细胞相比的功能增强.
  • 在临床前疾病模型中成功应用设计性淋巴细胞.
  • 扩大细胞治疗的治疗窗口.

结论:

  • 设计性淋巴细胞代表了治疗可能性的重大进步.

更多相关视频

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.7K
Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist
07:48

Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist

Published on: April 25, 2018

6.3K

相关实验视频

Last Updated: Aug 17, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.3K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.7K
Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist
07:48

Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist

Published on: April 25, 2018

6.3K
  • 工程免疫细胞为治疗各种疾病提供了多功能平台.
  • 这种方法扩大了个性化医疗和再生疗法的范围.